Ipilimumab

CTLA-4-directed Blocking Antibody

Brands

Ipilimumab may treat:

Ipilimumab desired effects:

  • Increased T Lymphocyte Activation

Ipilimumab drug classes:

  • CTLA-4-directed Blocking Antibody

Ipilimumab pharmacologic actions:

  • Antineoplastic Agents, Immunological
  • Immune Checkpoint Inhibitors

Ipilimumab mechanism of action:

  • CTLA-4-directed Antibody Interactions
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 10/19/2022, 7:19:44 AM